1.Economic and Quality of Life Benefits of Anti-VEGF Therapy

Hodgson, N, Wu, F, Z     More...

Hodgson, N, Wu, F, Zhu, J, Wang, WQ, Ferreyra, H, Zhang, K, Wang, JW     Less

MOLECULAR PHARMACEUTICS[1543-8384], Published 2016, Volume 13, Issue 9, Pages 2877-2880

收錄情况： WOS SCOPUS

WOS核心合集引用: 18  2022影響因子:  4.9  发表年影響因子:  4.440 

2.Joint Antiangiogenic Effect of ATN-161 and Anti-VEGF Antibody in a Rat Model of Early Wet Age-Related Macular Degeneration

Wang, WQ, Wang, FH,     More...

Wang, WQ, Wang, FH, Qin, WX, Liu, HY, Lu, B, Chung, C, Zhu, J, Gu, Q, Shi, W, Wen, C, Wu, F, Zhang, K, Sun, XD     Less

MOLECULAR PHARMACEUTICS[1543-8384], Published 2016, Volume 13, Issue 9, Pages 2881-2890

收錄情况： WOS SCOPUS

WOS核心合集引用: 12  2022影響因子:  4.9  发表年影響因子:  4.440